Last $0.03 SGD
Change Today 0.00 / 0.00%
Volume 1.8M
ADVT On Other Exchanges
Symbol
Exchange
Singapore
As of 10:00 PM 09/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Poh Chye Tan

Independent Non-Executive Director, Member of Audit Committee and Member of Remuneration & Nomination Committee, Avexa Ltd.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 2 different industries.

See Board Relationships
49A$62,000

Background*

Mr. Tan Poh Chye, also known as Allan, has been a Partner of Colin Ng & Partners since 2006. Mr. Tan served as an Associate Director of Yeo-Leong & Peh LLC from 2004 to 2006. Mr. Tan was a Partner of Arthur Loke Bernard Rada & Lee since 2003. Mr. Tan served as Vice President of Legal & Corporate Affairs of Strategic Intelligence Pte Ltd. from 2000 to 2002. Mr. Tan served as a Legal Manager of Singapore Press Holdings Ltd. from 1999 to 2000. Mr. Tan served as an Associate ...

Read Full Background

Corporate Headquarters*

No 05-09, Maxwell House
Singapore, -- 069113

Singapore

Phone: 65 6382 2110
Fax: 65 6382 2420

Board Members Memberships*

2008-2014
Former Non-Executive Independent Director, Chairman of Nominating Committee, Member of Remuneration Committee and Member of Audit Committee
2010-Present
Independent Non-Executive Director, Member of Audit Committee and Member of Remuneration & Nomination Committee

Education*

MA
London Metropolitan University
LLB
University of Buckingham

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash CompensationA$62,000
Total Calculated CompensationA$62,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ADVT:SP $0.03 SGD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADVENTUS HOLDINGS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.